Citigroup Inc. upgraded shares of Ono Pharmaceutical Co., Ltd. (Japan) (NASDAQ:OPHLY) from a neutral rating to a buy rating in a research report sent to investors on Thursday morning, The Fly reports.

Shares of Ono Pharmaceutical Co., Ltd. (OPHLY) opened at 7.55 on Thursday. Ono Pharmaceutical Co., Ltd. has a 52-week low of $6.57 and a 52-week high of $10.16. The stock’s 50 day moving average price is $6.90 and its 200-day moving average price is $7.05. The firm has a market capitalization of $11.81 billion and a PE ratio of 24.12.

COPYRIGHT VIOLATION WARNING: “Ono Pharmaceutical Co., Ltd. (Japan) (OPHLY) Rating Increased to Buy at Citigroup Inc.” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/ono-pharmaceutical-co-ltd-japan-ophly-rating-increased-to-buy-at-citigroup-inc/1602945.html.

The Fly

Receive News & Ratings for Ono Pharmaceutical Co. Ltd. (Japan) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical Co. Ltd. (Japan) and related companies with Analyst Ratings Network's FREE daily email newsletter.